U.S. Construction Stock News

Acuity (AYI) heads into its upcoming Q3 earnings report with expectations for slightly higher earnings per share and overall revenue, as investors watch contrasting outlooks for its Intelligent Spaces and Brands Lighting segments. See our latest analysis for Acuity. Acuity’s recent share price momentum has picked up, with a 1 month share price return of 11.85% and a 3 month share price return of 13.72%. This is occurring even though the year to date share price return is down 13.84%, while...

Rising stress in the Federal Reserve’s Main Street Lending Program, where nearly 30% of borrowers are flagged as at risk of default and about 70% struggled with final balloon payments, is putting a harsh spotlight on small business credit risk. For investors, this is less about headline noise and more about which stocks are sitting closest to that pressure. This article breaks down 3 stocks that appear negatively exposed to the latest data on small and midsize business loan performance,...

Navigator Holdings Ltd recently announced that its subsidiaries have secured financing to support the construction and delivery of two new gas carriers in China, with vessel deliveries scheduled for 2027. This fleet expansion underscores the company’s intent to boost liquefied gas transportation capacity, potentially reinforcing its role in a growing niche shipping market. We will now examine how this newly secured vessel financing shapes Navigator Holdings’ investment narrative,...

In the past quarter, Polen Capital highlighted TechnipFMC as a top contributor in its portfolio, citing strong order intake, a growing backlog, and better execution in offshore energy projects. This recognition underscores how operational improvements and margin expansion are shaping investor perception of TechnipFMC’s role in the offshore development cycle. Next, we’ll examine how TechnipFMC’s strong order intake and expanding backlog may influence its existing investment narrative and risk...

Opera Limited announced that its Board of Directors has declared a semi-annual cash dividend of US$0.40 per share, payable on or about July 14, 2026, to shareholders of record as of July 7, 2026. This semi-annual dividend policy highlights Opera’s ongoing commitment to returning cash to both ordinary shareholders and ADS holders through direct payouts. Next, we’ll explore how Opera’s decision to declare a US$0.40 semi-annual dividend shapes the company’s broader investment narrative. Invest...

Cinemark Holdings (CNK) is in focus after reporting its biggest ever three-day domestic opening weekend for a G or PG film with Toy Story 5, alongside record June weekend box office performance. See our latest analysis for Cinemark Holdings. The strong Toy Story 5 weekend comes on top of a 27.17% 1 month share price return and a 42.84% year to date share price return for Cinemark Holdings, while the 3 year total shareholder return of 115.07% shows how sentiment has shifted over a longer...

Kaspi.kz recently held an Extraordinary General Meeting where shareholders approved a special cash dividend of KZT 850 (US$1.74) per common share, with payments commencing on 11 June 2026 based on a 10 June 2026 record date. By pairing this one-off payout with affirmed ongoing dividends and refreshed counting commission appointments, the company underlined its emphasis on returning capital to shareholders while maintaining governance oversight. Now we’ll consider how this special dividend...

OFG Bancorp (OFG) is coming into focus as it prepares to report second quarter 2026 results on July 21, with investors weighing recent margin pressure and muted net interest income against the stock’s strong multiyear total returns. See our latest analysis for OFG Bancorp. The upcoming second quarter update comes after a period where OFG Bancorp’s share price has shown building momentum, with a 30 day share price return of 4.75% and a 90 day share price return of 18.27%. The 5 year total...

Earlier in June 2026, SEI Investments announced an enhanced, unified platform for public and private market investment managers, combining its SEI Data Cloud with the SEI Scope portal to improve data access, transparency, and operational efficiency, while also rolling out AI, automation, and onboarding tools across its investment manager technology ecosystem. Just days later, SEI added Matt Provencher as Global Head of Enterprise Professional Services, formalizing a firmwide push to pair its...

Madrigal Pharmaceuticals recently filed a US$717.70 million shelf registration for up to 1,431,985 common shares, while also granting four-year vesting restricted stock units to five new non-executive employees under its 2025 Inducement Plan. Together, the potential equity issuance and inducement grants highlight Madrigal’s ongoing use of stock-based funding tools to support growth and talent retention while preserving operational flexibility. We’ll now examine how Madrigal’s new shelf...

In the most recent quarter, DNOW reported revenue that came in well above analyst expectations, delivering the fastest top-line growth among its industrial distribution peers, even though adjusted operating income fell short of forecasts. This mix of stronger-than-expected sales and an earnings miss underscores how DNOW’s supply chain strengths, rapid delivery, and omnichannel investments are supporting customer demand despite profitability pressures. Now we’ll explore how DNOW’s outsized...

Mirum Pharmaceuticals (MIRM) stock is in focus after the company and Incyte reported pivotal Phase 2 data for zilurgisertib in fibrodysplasia ossificans progressiva, alongside FDA Priority Review of its New Drug Application. See our latest analysis for Mirum Pharmaceuticals. At a share price of $107.13, Mirum Pharmaceuticals has seen strong recent momentum, with a 30 day share price return of 8.63% and a year to date share price return of 37.22%. The 1 year total shareholder return of 113.09%...

Borr Drilling (BORR) has moved to reshape its balance sheet with a large debt refinancing. The company reported early tender results for its high coupon senior secured notes and outlined plans for new, longer-dated borrowings. See our latest analysis for Borr Drilling. The refinancing headlines arrive after a mixed period for Borr Drilling’s stock, with the 1-day share price return of 2.84% contrasting with a 30-day share price return down 21.38%. Over a longer horizon, the 1-year total...

In recent weeks, UnitedHealth Group subsidiaries OptumRx and Emisar Pharma Services agreed to settle Federal Trade Commission allegations over past insulin rebating practices, while the parent company outlined a planned US$3.00 billion artificial intelligence investment for 2026 and 2027 aimed at improving efficiency and cutting operating costs. This combination of resolving a regulatory overhang and committing substantial capital to AI-driven automation and cost reduction could reshape how...

Earlier this month, Plug Power Inc. filed a US$66.25 million shelf registration for 25,000,000 common shares tied to an ESOP-related offering, while also raising cash by selling federal investment tax credits connected to its St. Gabriel and Woodbine hydrogen facilities. This combination of equity capacity and tax credit monetization highlights how Plug Power is using policy incentives and capital-market tools to support its capital-intensive hydrogen build-out while easing liquidity...

Morgan Stanley’s updated outlook on PBF Energy (PBF), tied to strong crack spreads, tight fuel inventories, and the return of the Martinez refinery to full capacity, has put fresh attention on the refiner’s cash generation prospects. See our latest analysis for PBF Energy. At a share price of $39.29, PBF Energy has seen a 1-day share price return of 5.36% and a year-to-date share price gain of 37.71%, alongside a 1-year total shareholder return of 86.63%. This indicates that recent momentum...

Teva Pharmaceutical Industries has submitted a New Drug Application to the US FDA for ecopipam, a first-in-class dopamine D1 antagonist for pediatric Tourette syndrome, supported by Phase 3 data in JAMA Neurology showing a statistically significant delay in time to relapse and a generally manageable safety profile. Alongside new evidence of comprehensive symptom improvement from AUSTEDO and AUSTEDO XR in tardive dyskinesia and Huntington’s disease chorea, the ecopipam filing underscores...

Artificial intelligence is moving from buzzword to real-world spending priority, even as global inflation, interest rates, and growth trends keep shifting. While central banks weigh inflation risks and bond yields move on policy headlines, companies behind AI chips, software, cloud, and large language models such as ChatGPT sit at the heart of that structural shift. This AI Stocks screener focuses on businesses that are directly tied to that trend, from semiconductors to infrastructure and...

Recently, Nutanix reported that its latest quarterly billings growth lagged sector peers amid intensifying competition and softer demand, even as operating margins improved. An interesting wrinkle is that some analysts now view Nutanix as only fairly valued despite better profitability, raising questions about how slowing growth could affect its longer-term appeal. Next, we’ll examine how this emerging deceleration in Nutanix’s growth could influence the company’s previously optimistic...

In June 2026, Flagstar Bank, National Association filed a provisional patent for StarIQ, its enterprise generative AI orchestration platform built for regulated financial services, which integrates models such as Anthropic Claude, Meta Llama, Mistral and Amazon Titan on Amazon Web Services and is secured by Palo Alto Networks. The patent application for StarIQ highlights Flagstar’s attempt to create a secure, governed multi-model AI infrastructure with embedded compliance controls,...

Planet Labs PBC (PL) stock is reacting to fresh U.S. government business after the National Geospatial Intelligence Agency extended its AI maritime monitoring contract and awarded a new Global Monitoring Service mandate. See our latest analysis for Planet Labs PBC. Against this contract backdrop, Planet Labs PBC’s 1 day share price return of 1.91% and current share price of $28.77 sit alongside a 7 day share price decline of 5.92% and a 30 day share price drop of 35.13%. At the same time, the...

Recently, Lithia Motors reported that institutional investors now hold a very large proportion of its shares, while its latest quarter showed slightly higher revenue and a strong increase in net profit despite an overall weak financial health score. This combination of growing institutional participation and improved profitability, even amid lingering balance sheet concerns, is reshaping how investors assess the company's risk and reward profile. We'll now examine how higher institutional...

Influential proxy advisers have publicly criticized Manchester United (NYSE:MANU) over board independence, the lack of a nominating committee, and limited disclosure of proxy voting results, putting the club’s governance practices in sharper focus for shareholders. See our latest analysis for Manchester United. Manchester United’s recent governance scrutiny comes as the stock trades at US$21.90, with a 30 day share price return of 9.5% and a 90 day share price return of 32.17%. The 1 year...

Immunocore Holdings plc recently reported updated Phase 1/2 data for its bispecific T cell receptor therapy brenetafusp in heavily pretreated advanced melanoma at the 2026 American Society of Clinical Oncology Annual Meeting, showing encouraging disease control and six‑month survival in patients with limited treatment options. The consistency of responses even in poor‑prognosis groups, including those with primary PD‑1 resistance, is strengthening confidence in the ongoing Phase 3...